Skip Ribbon Commands
Skip to main content

Yen Choo

Yen photo_cropped (Custom).jpg 




​Associate Professor Yen CHOO
​Associate Professor of Stem Cell Science and Regenerative Medicine ​
Research Programme: Developmental/Stem Biology & Regenerative Medicine​​


Associate Professor Yen Choo obtained his PhD in Molecular Biology in 1995 from the University of Cambridge, England, researching sequence-specific protein-DNA interactions under Nobel laureate Sir Aaron Klug. He subsequently directed the zinc finger engineering group at the world-renowned MRC Laboratory of Molecular Biology, Cambridge, before moving to industry.

A/Prof Choo is a serial entrepreneur with over 20 years of C-level and Board experience in the biotechnology industry. He was the founder and CSO of Gendaq, the biotech company that developed the zinc finger DNA-binding technology now used for gene editing (acquired by Sangamo Therapeutics). He is the founder and Chairman of Plasticell, one of the UK’s pioneering stem cell and regenerative medicine companies. He was also the founder of Progenitor Therapeutics, a drug discovery company established jointly with GSK to discover medicines that regenerate tissues of the human body (acquired by Plasticell). 

His research, inventions and companies have been recognised by an array of awards and prizes including The Queen’s Award in Enterprise for Innovation, The Scientist Top 10 Innovations and the GE Healthcare and Science Prize for Young Scientists.

He sits on the Steering Committee for the UK Stem Cell Bank and for the Use of Stem Cell Lines which oversees UK embryonic stem cell research and the UK Stem Cell Bank.


Not sure which programme to go for? Use our programme finder
Loading header/footer ...